NRX Pharmaceuticals, Inc.

Big Rock Partners Acquisition Corp., trading under the ticker BRPA, is a blank-check company sponsored by Big Rock Partners that completed its initial public offering in 2018, targeting the healthcare and pharmaceutical sector. The SPAC filed a 10-K with the SEC on March 30, 2020, covering fiscal year 2019, under accession number 0001654954-20-003527. At the time of filing, the company was operating under the name NRX Pharmaceuticals, Inc., reflecting its focus on biopharmaceutical targets. The vehicle pursued a business combination within the life sciences space, consistent with its stated acquisition mandate. Visit SpacDesk and sign up for full data on BRPA, including filing history, deal timelines, and sponsor profiles.